New Delhi: Amid the reports of shortage medical oxygen and anti-viral drug Remdesivir in different parts of country, Dr Naresh Trehan, Chairman, Medanta, on Wednesday said that Remdesivir is not 'Rambaan' in treatment of COVID-19 and it only decreases viral load in people who need it.
He also urged people not to use oxygen as a "security blanket" if they do not need it. Speaking on issues related to COVID-19 through video conferencing, Dr Trehan said that less percentage of COVID-19 patients require hospitalization.
Read:Serum Institute prices Covishield at Rs 400/dose for govts; Rs 600/dose for pvt hospitals
"The hospital beds should be utilised judiciously and with responsibility. This responsibility rests on all of us," he said.
He said Remdesivir is to be given only after doctors look at test results, symptoms and comorbidities of a patient.
"Remdesivir is not a 'Rambaan', it only decreases viral load in people who need it," he said. Referring to reports of shortage of medical oxygen, Dr Trehan cautioned against its wastage.
"Today we have enough oxygen if we try to use it judiciously. I want to tell the public that if you do not need oxygen then do not use it as a security blanket. Wastage of oxygen will only lead to depriving someone who needs it," he said.
Read:Over 21k tested positive for COVID after taking first dose of either Covishield or Covaxin: Govt